Zobrazeno 1 - 10
of 47
pro vyhledávání: '"A.A.M. Franken"'
Autor:
Madeleine L. Drent, H. P. F. Koppeschaar, N. C. van Varsseveld, C.C. van Bunderen, A. J. van der Lely, A.A.M. Franken
Publikováno v:
van Varsseveld, N C, van Bunderen, C C, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2016, ' Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults ', Pituitary, vol. 19, no. 4, pp. 381-90 . https://doi.org/10.1007/s11102-016-0716-3
Pituitary
Pituitary, 19(4), 381-390. Kluwer Academic
Pituitary, 19(4), 381-90. Kluwer Academic Publishers
Pituitary, 19(4), 381-390. Kluwer Academic Publishers
van Varsseveld, N C, van Bunderen, C C, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2016, ' Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults ', Pituitary, vol. 19, no. 4, pp. 381-390 . https://doi.org/10.1007/s11102-016-0716-3
Pituitary
Pituitary, 19(4), 381-390. Kluwer Academic
Pituitary, 19(4), 381-90. Kluwer Academic Publishers
Pituitary, 19(4), 381-390. Kluwer Academic Publishers
van Varsseveld, N C, van Bunderen, C C, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2016, ' Fractures in pituitary adenoma patients from the Dutch National Registry of Growth Hormone Treatment in Adults ', Pituitary, vol. 19, no. 4, pp. 381-390 . https://doi.org/10.1007/s11102-016-0716-3
PURPOSE: The effects of growth hormone (GH) replacement therapy on fracture risk in adult GH deficient (GHD) patients with different etiologies of pituitary GHD are not well known, due to limited data. The aim of this study was to investigate charact
Autor:
Madeleine L. Drent, C.C. van Bunderen, H. P. F. Koppeschaar, Martijn W. Heymans, N. C. van Varsseveld, A.A.M. Franken, A. J. van der Lely
Publikováno v:
European Journal of Endocrinology, 171(6), 717-726. Bioscientifica Ltd
European Journal of Endocrinology, 171(6), 717-726. BioScientifica Ltd.
van Bunderen, C C, van Varsseveld, N C, Heymans, M W, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2014, ' Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults ', European Journal of Endocrinology, vol. 171, no. 6, pp. 717-726 . https://doi.org/10.1530/EJE-14-0515
European Journal of Endocrinology, 171(6), 717-726. BioScientifica Ltd.
van Bunderen, C C, van Varsseveld, N C, Heymans, M W, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2014, ' Effect of long-term GH replacement therapy on cardiovascular outcomes in GH-deficient patients previously treated for acromegaly: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults ', European Journal of Endocrinology, vol. 171, no. 6, pp. 717-726 . https://doi.org/10.1530/EJE-14-0515
ObjectiveThe effect of GH deficiency (GHD) on the metabolic profile of acromegaly patients is unclear in patients previously treated for acromegaly, as are the efficacy and safety of GH treatment in this particular group. The aim of the study is to d
Autor:
Aart Jan van der Lely, A.A.M. Franken, H. P. F. Koppeschaar, Lucia I. Arwert, Christa C. van Bunderen, Madeleine L. Drent, I. Caroline van Nieuwpoort, Martijn W. Heymans
Publikováno v:
Journal of Clinical Endocrinology and Metabolism, 96(10), 3151-3159. The Endocrine Society
van Bunderen, C C, van Nieuwpoort, I C, Arwert, L I, Heijmans, M W, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2011, ' Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch national registry of growth hormone treatment in adults ', Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 10, pp. 3151-3159 . https://doi.org/10.1210/jc.2011-1215
Journal of Clinical Endocrinology and Metabolism, 96(10), 3151-3159. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 96(10), 3151-3159. Endocrine Society
van Bunderen, C C, van Nieuwpoort, I C, Arwert, L I, Heijmans, M W, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2011, ' Does growth hormone replacement therapy reduce mortality in adults with growth hormone deficiency? Data from the Dutch national registry of growth hormone treatment in adults ', Journal of Clinical Endocrinology and Metabolism, vol. 96, no. 10, pp. 3151-3159 . https://doi.org/10.1210/jc.2011-1215
Journal of Clinical Endocrinology and Metabolism, 96(10), 3151-3159. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 96(10), 3151-3159. Endocrine Society
Context: Adults with GH deficiency (GHD) have a decreased life expectancy. The effect of GH treatment on mortality remains to be established. Objective: This nationwide cohort study investigates the effect of GH treatment on all-cause and cause-speci
Autor:
Varsseveld Nadege van, Hans P. F. Koppeschaar, Bunderen Christa C. van, A.A.M. Franken, der Lely Aart Jan van, Madeleine L. Drent
Publikováno v:
Endocrine Abstracts.
Autor:
N. C. van Varsseveld, C.C. van Bunderen, H. P. F. Koppeschaar, A.A.M. Franken, A. J. van der Lely, Madeleine L. Drent
Publikováno v:
van Varsseveld, N C, van Bunderen, C C, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2015, ' Tumor Recurrence or Regrowth in Adults With Nonfunctioning Pituitary Adenomas Using GH Replacement Therapy ', Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 8, pp. 3132-3139 . https://doi.org/10.1210/jc.2015-1764
Journal of Clinical Endocrinology and Metabolism, 100(8), 3132-3139. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(8), 3132-3139. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(8), 3132-3139. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(8), 3132-3139. Endocrine Society
Context: GH replacement therapy (GH-RT) is a widely accepted treatment in GH-deficient adults with nonfunctioning pituitary adenoma (NFPAs). However, some concerns have been raised about the safety of GH-RT because of its potentially stimulating effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e67387bcda19c448ad6d3bb2a9222ad8
https://research.vumc.nl/en/publications/af5a1592-cd1f-4e3f-8c70-5d6c5dcfee4b
https://research.vumc.nl/en/publications/af5a1592-cd1f-4e3f-8c70-5d6c5dcfee4b
Autor:
D. H. H. Ubachs, Madeleine L. Drent, A. J. van der Lely, C.C. van Bunderen, N. C. van Varsseveld, A.A.M. Franken, H. P. F. Koppeschaar
Publikováno v:
van Varsseveld, N C, van Bunderen, C C, Ubachs, D H H, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2015, ' Cerebrovascular Events, Secondary Intracranial Tumors, and Mortality After Radiotherapy for Nonfunctioning Pituitary Adenomas: A Subanalysis From the Dutch National Registry of Growth Hormone Treatment in Adults ', Journal of Clinical Endocrinology and Metabolism, vol. 100, no. 3, pp. 1104-1112 . https://doi.org/10.1210/jc.2014-3697
Journal of Clinical Endocrinology and Metabolism, 100(3), 1104-1112. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(3), 1104-1112. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(3), 1104-1112. Oxford University Press
Journal of Clinical Endocrinology and Metabolism, 100(3), 1104-1112. The Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(3), 1104-1112. Endocrine Society
Journal of Clinical Endocrinology and Metabolism, 100(3), 1104-1112. Oxford University Press
Context Radiotherapy is frequently administered as adjuvant treatment in patients with clinically nonfunctioning pituitary adenomas (NFPAs). However, concerns have been raised about potential long-term side effects, including cerebrovascular events (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6337d67b72d529c0a8a03400cb5b3c
https://hdl.handle.net/1871.1/146a2f5e-349f-46f0-a2a4-67c0d06e3a2c
https://hdl.handle.net/1871.1/146a2f5e-349f-46f0-a2a4-67c0d06e3a2c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Madeleine L. Drent, Christa C. van Bunderen, Martijn W. Heymans, Carline J van den Dries, A.A.M. Franken, H. P. F. Koppeschaar, Aart Jan van der Lely
Publikováno v:
European Journal of Endocrinology, 171(2), 151-160. BioScientifica Ltd.
European Journal of Endocrinology, 171(2), 151-160. Bioscientifica Ltd
van Bunderen, C C, van den Dries, C J, Heijmans, M W, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2014, ' Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults ', European Journal of Endocrinology, vol. 171, no. 2, pp. 151-160 . https://doi.org/10.1530/EJE-14-0069
European Journal of Endocrinology, 171(2), 151-160. Bioscientifica Ltd
van Bunderen, C C, van den Dries, C J, Heijmans, M W, Franken, A A M, Koppeschaar, H P F, van der Lely, A J & Drent, M L 2014, ' Effect of long-term GH replacement therapy on cardiovascular outcomes in isolated GH deficiency compared with multiple pituitary hormone deficiencies: a sub-analysis from the Dutch National Registry of Growth Hormone Treatment in Adults ', European Journal of Endocrinology, vol. 171, no. 2, pp. 151-160 . https://doi.org/10.1530/EJE-14-0069
ObjectiveIsolated GH deficiency (IGHD) could provide a model to investigate the influence of GH deficiency per se and the effect of GH replacement therapy without the influence from other pituitary hormone deficiencies or their treatment. The aim of
Autor:
R. Zalm, J. Peter H. Burbach, Henk Engel, Erica L T van den Akker, Marga Nijenhuis, Andre P. Abbes, A.A.M. Franken, David de Wied
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 86:3410-3420
Familial neurohypophysial diabetes insipidus (FNDI) is an autosomal dominant trait in which expression of a mutant vasopressin prohormone reduces vasopressin production. We investigated the NP85 Cys→Gly mutant vasopressin prohormone in a large kind
Autor:
H. P. F. Koppeschaar, C.C. van Bunderen, Madeleine L. Drent, I.C. van Nieuwpoort, Lucia I. Arwert, A.A.M. Franken, Jos W. R. Twisk, A J van der Lelij, M Boers
Publikováno v:
van Nieuwpoort, I C, van Bunderen, C C, Arwert, L I, Franken, A A M, Koppeschaar, H P F, van der Lelij, A J, Twisk, J W, Boers, M & Drent, M L 2011, ' Dutch national registry of GH Treatment in adults: patient characteristics and diagnostic test procedures ', European Journal of Endocrinology, vol. 164, no. 4, pp. 491-497 . https://doi.org/10.1530/EJE-10-0914
European Journal of Endocrinology, 164(4), 491-497. Bioscientifica Ltd
European Journal of Endocrinology, 164(4), 491-497. BioScientifica Ltd.
European Journal of Endocrinology, 164(4), 491-497. Bioscientifica Ltd
European Journal of Endocrinology, 164(4), 491-497. BioScientifica Ltd.
ObjectiveThe Dutch National Registry of GH Treatment in Adults was established in 1998 as an initiative of the Ministry of Health. The main goals were to gain more insight into long-term efficacy, safety, and costs of GH therapy (GHT) in adult GH-def
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68ed064da3e8b8b90c4981825d2137e8
https://research.vumc.nl/en/publications/26e9faca-a9c1-48c0-b641-de83f92d0fbe
https://research.vumc.nl/en/publications/26e9faca-a9c1-48c0-b641-de83f92d0fbe